Modalis Therapeutics Corporation announced consolidated earnings results for the first quarter ended March 31, 2021. For the period, the company reported operating revenue of JPY 0 million against JPY 13 million a year ago. Operating loss was JPY 252 million against JPY 116 million a year ago. Profit attributable to owners of parent was JPY 201 million against loss of JPY 118 million a year ago. Basic earnings per share was JPY 7.07 against net loss per share of JPY 4.71 per share a year ago. Diluted earnings per share of JPY 6.66.